We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Sigma-Aldrich Dlk Inhibitor, Gne-3511
List Price
$253.34
Your Price
$253.34
Sigma-Aldrich Dlk Inhibitor, Gne-3511 - Calbiochem; 1ea; >=98% (Hplc) - SIAL (Additional S&H Or Hazmat Fees May Apply)
NETA PART:
SIAL-5331680001
MFG.PART:
5331680001
UNSPSC:
41115709
Manufacturer:
Sigma-Aldrich
Assay
≥98% (HPLC)
Quality Level
100
Form
solid
Manufacturer/Tradename
Calbiochem®
Storage Condition
OK to freeze
protect from light
Color
yellow
Solubility
DMSO: 20 mg/mL
Storage Temp.
2-8°C
General Description
A cell-permeable, orally bioavailable, blood-brain barrier permeant 2,6-diaminopyridine based compound that acts as a highly potent and selective inhibitor of dual leucine zipper kinase inhibitor (DLK; Ki= 500 pM). Exhibits an ideal balance of metabolic stability, potency, and efflux properties. Displays high selectivity over JNK (IC50= 129, 514, and 364 nM for JNK1, 2, and 3, respectively) and MLK (IC50= 67.8, 767, and 602 nM for MLK1, 2, and 3, respectively). Does not affect the activities of MKK4 and MKK7 (IC50>5 µM). Protects neurons in anin vitroaxon degeneration assay (IC50= 107 nM). Also shown to reduce levels of phosphorylated c-Jun in retina and offer protection in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MTPT) model of Parkinson′s disease. Exhibits desirable pharmacokinetic properties (t1/2 = 0.6 h; CLp = 56 ml/min/kg in mice; 1 mg/kg, i.v., or 5 mg/kg; p.o.).A cell-permeable, orally bioavailable, blood-brain barrier permeant 2,6-diaminopyridine based compound that acts as a highly potent and selective inhibitor of dual leucine zipper kinase inhibitor (DLK; Ki= 500 pM). Exhibits an ideal balance of metabolic stability, potency, and efflux properties. Displays high selectivity over JNK (IC50= 129, 514, and 364 nM for JNK1, 2, and 3, respectively) and MLK (IC50= 67.8, 767, and 602 nM for MLK1, 2, and 3, respectively). Does not affect the activities of MKK4 and MKK7 (IC50>5 µM). Protects neurons in anin vitroaxon degeneration assay (IC50= 107 nM). Also shown to reduce levels of phosphorylated c-Jun in retina and offer protection in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MTPT) model of Parkinson′s disease. Exhibits desirable pharmacokinetic properties (t1/2 = 0.6 h; CLp = 56 ml/min/kg in mice; 1 mg/kg, i.v., or 5 mg/kg; p.o.).Please note that the molecular weight for this compound is batch-specific due to variable water content. Please refer to the vial label or the certificate of analysis for the batch-specific molecular weight. The molecular weight provided represents the baseline molecular weight without water.
Biochem/Physiol Actions
Cell permeable: yesPrimary TargetDLKReversible: yes
Packaging
Packaged under inert gasWarning
Toxicity: Standard Handling (A)Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.Other Notes
Patel, S., et al. 2014.J. Med. Chem. 57,in press.CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany| SKU | SIAL-5331680001 |
|---|---|
| Featured | No |
| Supplier Part Number | 5331680001 |
| UM | EA |
| UNSPSC | 41115709 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIAL |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 9 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| ACT Ecolabel | No |
| Controlled | N |